Antimicrobial susceptibility of Streptococcus pneumoniae in pediatric and adult population from Santiago, 1997-2003;Susceptibilidad a antimicrobianos de Streptococcus pneumoniae en poblacion infantil y adulta de Santiago. Periodo 1997-2003

Revista Medica de Chile

Volumn 133, Issue 1, 2005, Pages 42-49

  Saldías P, Fernando ^a   Flores S, Luis José ^a   Torres M, Catalina ^a   García C, Patricia ^a   Díaz F, Alejandro ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Drug resistance, bacterial; Pneumococcal infections; Streptococcus pneumoniae

Indexed keywords

ANTIINFECTIVE AGENT; PENICILLIN DERIVATIVE;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; CHILE; DRUG EFFECT; FEMALE; HUMAN; INFANT; ISOLATION AND PURIFICATION; MALE; PRESCHOOL CHILD; PROSPECTIVE STUDY; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; CHILE; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT; MALE; PENICILLINS; PROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE;

EID: 27744455144     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. BERMAN S. Epidemiology of acute respiratory infections in children of developing countries. Rev Infect Dis 1991; Suppl 6: S454-62.
2. WILLIAMS BG, GOUWS E, BOSCHI-PINTO C, BRYCE J, DYE C. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis 2002; 2: 25-32.
3. DUNBAR IM. Current issues in the management of bacterial respiratory tract disease: the challenge of antibacterial resistance. Am J Med Sci 2003; 326: 360-8.
4. TAN TQ. Update on pneumococcal infections of the respiratory tract. Semin Respir Infect 2002; 17: 3-9.
5. BISHAI WR. Issues in the management of bacterial sinusitis. Otolaryngol Head Neck Surg 2002; 127 (6 Suppl): S3-9.
6. WOODHEAD M. Community-acquired pneumonia in Europe: causative pathogens and resistance patterns. Eur Resp J Suppl 2002; 36: 20S-27S.
7. MUSHER DM. How contagious are common respiratory tract infections? N Engl J Med 2003; 348: 1256-66.
8. CASAL J, TARRAGO D. Immunity to Streptococcus pneumoniae: Factors affecting production and efficacy. Curr Opin Infect Dis 2003; 16: 219-24.
9. KOEDEL U, SCHELD WM, PFISTER HW. Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis 2002; 2: 721-36.
10. HANSMAN D, BULLEN MM. A resistant pneumococcus. Lancet 1967; 2: 264-5.
11. CAMPBELL GD JR, SILBERMAN R. Drug-resistant Streptococcus pneumoniae. Clin Infect Dis 1998; 26: 1188-95.
12. DOERN GV, HEILMANN KP, HUYNH HK, RHOMBERG PR, COFFMAN SL, BRUEGGEMAN AB. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob Agents Chemother 2001; 45: 1721-9.
13. MOELLERING RC JR, CRAIG W, EDMOND M, FARRELL DJ, FERRARO MJ, FILE TM JR, KLEIN J, LONKS J, METLAY JP, SAHM D, TALBOT GH; CONSENSUS WORKING GROUP. Clinical and public health implications of macrolide-resistant Streptococcus pneumoniae. J Chemother 2002; 14 (suppl 3): 42-56.
14. WASHINGTON JA, AND THE ALEXANDER PROJECT GROUP. A multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract pathogens in the United States, 1992-1994. Diagn Microbiol Infect Dis 1996; 25: 183-90.
15. Programa de Infecciones Respiratorias Agudas (IRA), Departamento de Estadísticas e Información de Salud, Ministerio de Salud de Chile, 2001.
16. BAQUERO F, MARTINEZ-BELTRAN J, LOZA E. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J Antimicrob Chemother 1991; 28 (Suppl C): 31-8.
17. PALLARES R, FENOLL A, LINARES J; THE SPANISH PNEUMOCOCCAL INFECTION STUDY NETWORK. The epidemiology of antibiotic resistance in Streptococcus pneumoniae and the clinical relevance of resistance to cephalosporins, macrolides and quinolones. Int J Antimicrob Agents 2003; 22 (Suppl 1): S15-24.
18. WENZEL RP, EDMOND MB. Managing antibiotic resistance. N Engl J Med 2000; 343: 1961-3.
19. DIAZ A, TORRES C, FLORES LJ, GARCIA P, SALDIAS F. Neumonía neumocócica adquirida en la comunidad en pacientes adultos hospitalizados. Rev Méd Chile 2003; 131: 505-14.
20. SOLER T, SALAMANCA L, ARBO G, MOLINA E. Estudio de sensibilidad in vitro de Streptococcus pneumoniae de infecciones respiratorias bajas en el Instituto Nacional del Tórax (INT). Rev Méd Chile 2002; 130: 304-8.
21. NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS. Performance standards for antimicrobial susceptibility testing. Twelve informational supplement M100-S12. Wayne, Pennsylvania: NCCLS, 2002.
22. PALAVECINO E. Puesta al día en el estudio de susceptibilidad de Streptococcus pneumoniae. Rev Chil Infect 2002; 19 (Supl. 2): S101-6.
23. BAVESTRELLO L, CABELLO A, CASANOVA D. Impacto de medidas regulatorias en la tendencia de consumo comunitario de antibióticos en Chile. Rev Méd Chile 2002; 130: 1265-72.
24. GONZÁLEZ P. Vigilancia de la resistencia a antimicrobianos. Rev Chil Infect 2002; 19 (Supl. 2): S135-9.
25. BEGG N, CARTWRIGHT KA, COHEN J, KACZMARSKI EB, INNES JA, LEEN CL ET AL. Consensus statement on diagnosis, investigation, treatment and prevention of acute bacterial meningitis in immunocompetent adults. British Infection Society Working Party. J Infect 1999; 39(1): 1-15.
26. NIEDERMAN MS, MANDELL LA, ANZUETO A, BASS JB, BROUGHTON WA, CAMPBELL GD ET AL. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163: 1730-54.
27. KLUGMAN KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990; 3: 171-96.
28. NAVA JM, BELLA F, GARAU J, LITE J, MORERA MA, MARTI C ET AL. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population based study. Clin Infect Dis 1994; 19: 884-90.
29. METLAY J, HOFMANN J, CETRON M, FINE M, FARLEY M, WHITNEY C, BREIMAN R. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2000; 30: 520-8.
30. MORONEY J, FIORE A, HARRISON L, PATTERSON J, FARLEY M, JORGENSEN J ET AL. Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance. Clin Infect Dis 2001; 33: 797-805.
31. FEIKIN DR, SCHUCHAT A, KOLCZAK M, BARRETT NL, HARRISON LH, LEFKOWITZ L ET AL. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health 2000; 90: 223-9.